CEACAM5 and colorectal carcinoma: To study the prognostic value of mSEPT9 in a surgical effectiveness and TTR in patients with stage I–III CRC, we tested peripheral mSEPT9 levels 7 days after surgery and simultaneously collected clinical regular examination results for CEA.